PMID- 15750169 OWN - NLM STAT- MEDLINE DCOM- 20050503 LR - 20191210 IS - 0161-5505 (Print) IS - 0161-5505 (Linking) VI - 46 IP - 3 DP - 2005 Mar TI - Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis. PG - 526-31 AB - Evaluating the efficacy of therapy in experimental inflammatory bowel disease (IBD) requires information about inflammatory activity in bowel segments or leukocyte recruitment and about kinetics in the follow-up of treatment. This study evaluated a noninvasive scintigraphic technique able to assess neutrophil trafficking in a mouse model of dextran sulfate sodium (DSS)-induced colitis. METHODS: Groups of 4 BALB/c mice were assessed at baseline and after 1, 3, 5, and 8 d of treatment with DSS. Donor neutrophils were harvested by rinsing of the peritoneal cavity with phosphate-buffered saline 5 h after intraperitoneal injection of proteose peptone contained in phosphate-buffered saline and labeled with freshly prepared (99m)Tc-hexamethylpropylene amine oxime (HMPAO). Pinhole SPECT of the abdomen was performed 1 h after reinjection of 50 MBq of labeled neutrophils. In addition, the severity of inflammation was determined by histologic examination. The possibilities of the technique were illustrated by scintigraphic assessment of neutrophil trafficking with and without blocking of neutrophil migration by a CD97 monoclonal antibody in mice with DSS-induced colitis. RESULTS: Colonic uptake of (99m)Tc-HMPAO neutrophils was determined with dedicated animal pinhole SPECT in mice with DSS-induced colitis and correlated well with histologic findings (R = 0.81) and wet colon weight (R = 0.87) and moderately with clinical weight loss (R = 0.62). The neutrophil uptake ratio was reduced significantly (P < 0.01) by blocking of neutrophil migration capacity with the CD97 antibody. CONCLUSION: Animal pinhole SPECT can be used to study inflammatory activity and neutrophil recruitment in vivo in experimental colitis. FAU - Bennink, Roelof J AU - Bennink RJ AD - Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands. r.bennink@amc.uva.nl FAU - Hamann, Jorg AU - Hamann J FAU - de Bruin, Kora AU - de Bruin K FAU - ten Kate, Fiebo J W AU - ten Kate FJ FAU - van Deventer, Sander J H AU - van Deventer SJ FAU - te Velde, Anje A AU - te Velde AA LA - eng PT - Evaluation Study PT - Journal Article PT - Validation Study PL - United States TA - J Nucl Med JT - Journal of nuclear medicine : official publication, Society of Nuclear Medicine JID - 0217410 RN - 0 (Radiopharmaceuticals) RN - 3B744AG22N (Technetium Tc 99m Exametazime) RN - 9042-14-2 (Dextran Sulfate) SB - IM MH - Animals MH - Colitis/chemically induced/*diagnostic imaging/*metabolism/pathology MH - Dextran Sulfate MH - Disease Models, Animal MH - Lymphocyte Activation MH - Mice MH - Mice, Inbred BALB C MH - Neutrophils/*diagnostic imaging/*metabolism MH - Radiopharmaceuticals/pharmacokinetics MH - Technetium Tc 99m Exametazime/*pharmacokinetics MH - Tomography, Emission-Computed, Single-Photon/*methods EDAT- 2005/03/08 09:00 MHDA- 2005/05/04 09:00 CRDT- 2005/03/08 09:00 PHST- 2005/03/08 09:00 [pubmed] PHST- 2005/05/04 09:00 [medline] PHST- 2005/03/08 09:00 [entrez] AID - 46/3/526 [pii] PST - ppublish SO - J Nucl Med. 2005 Mar;46(3):526-31.